Results of activities on the safety of medicinal products

Professional development Vacancies
Results of activities on medicinal product safety
Summary data on adverse reactions following the use of vaccines and tuberculin for Q2 2026

Data summarized by the Pharmacovigilance Monitoring Department on the frequency of adverse reactions after the use of vaccines and tuberculin for the second quarter of 2026, based on information from 14 regions of Ukraine. Contains a breakdown of manifestations by vaccine type, number of immunized persons, and frequency of general, local, and other reactions. generated automatically

Read more
Summary data on adverse reactions following the use of vaccines and tuberculin for Q1 2026

Summary data on cases of adverse reactions following the use of vaccines and tuberculin for the first quarter of 2026, compiled from information from 11 regions of Ukraine. Contains the distribution of the frequency of general, local, and other manifestations of adverse reactions by vaccine type and number of immunized persons. generated automatically

Read more
Key performance indicators of the pharmacovigilance system of Ukraine for 2025

The document contains statistical indicators of the functioning of the pharmacovigilance system of Ukraine for 2025: the number of reports received on adverse reactions and adverse events following immunization by region, as well as the distribution of medicinal products by ATC pharmacological groups. Intended for pharmacovigilance specialists, researchers and health care analysts. compiled automatically

Read more
Summary data on adverse reactions following the use of vaccines and tuberculin for Q4 2025

Data summarized by the Pharmacovigilance Department on the frequency of adverse reactions after the use of vaccines and tuberculin for Q4 2025, collected from 12 regions of Ukraine. Contains a breakdown of manifestations by vaccine type, batch, manufacturer and number of immunized persons. compiled automatically

Read more
Summary data on adverse reactions following the use of vaccines and tuberculin for Q3 2025

Summary data on cases of adverse reactions following the use of vaccines and tuberculin for the third quarter of 2025, compiled by the Pharmacovigilance Department on the basis of information from 11 regions of Ukraine. Contains calculations of the frequency of general, local and other manifestations of adverse reactions by vaccine type and number of immunized persons. compiled automatically

Read more
Summary data on adverse reactions following the use of vaccines and tuberculin for Q2 2025

Read more
Summary data on adverse reactions following the use of vaccines and tuberculin for Q1 2025

Read more
Summary data on adverse reactions following the use of vaccines and tuberculin for Q4 2024

Read more
Key performance indicators of the pharmacovigilance system of Ukraine for 2024

Annual report on the key indicators of the functioning of the pharmacovigilance system in Ukraine for 2024. Contains statistics on received reports of adverse reactions and adverse events following immunization, broken down by region, pharmacotherapeutic group and individual medicinal products. generated automatically

Read more
Summary data on adverse reactions following the use of vaccines and tuberculin for Q3 2024

Read more